# Scotts Miracle-Gro share price today (The Scotts Miracle-Gro Company, SMG)

> The Scotts Miracle-Gro Company's balance sheet is under water: its net worth is negative, so it owes more than it owns. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. SMG · Materials · Agricultural Inputs · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/smg

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $61.80 (+15.5% in a year)
- P/E: 49.5× (higher than 65% of the last 4.6 years)
- Revenue (Jun 2026): $1.2 B (+1.1% on a year ago)
- Profit (Jun 2026): $112 M (−24.7% on a year ago)
- Operating margin: 16.8% (−2.4 points on a year ago)
- ROE: −41%, FY25
- ROIC: 13.8%, against a 9.7% cost of capital: +4.1 points
- Profit that came in as cash: 98%, last 2 years

Biggest thing to watch: the P/E is higher than 65% of its own history, so the multiple has already done part of the work. ## What is the Scotts Miracle-Gro share price today? The Scotts Miracle-Gro Company's share price was $61.80 at the close on 3 November 2026. It has been moving sideways for 1 week. That is 0.1% below its average price over the last 200 trading days. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row. In the last 52 weeks it traded between $49 and $71, and at that close it sat 58% of the way up from that low. Over the last 10 years the share price moved −17% while the S&P 500 moved +255%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Scotts Miracle-Gro pay? The Scotts Miracle-Gro Company paid $2.64 per share over the last four reported quarters. The most recent declaration was $0.66 for Jun 2026. At today's price of $61.80 that is a yield of 4.27%, based on dividends already paid, not a forecast. ## Which stock lists is Scotts Miracle-Gro on? Scotts Miracle-Gro is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Scotts Miracle-Gro profitable? The Scotts Miracle-Gro Company earned $112 M of net profit in the Jun 2026 quarter, −24.7% on the same quarter a year earlier. Full-year FY25 profit was $145 M. Over 4 years profit has grown −27.1% a year on average. That is 9.6% of the quarter's revenue. The same quarter a year earlier earned $149 M. 6 of the last 12 reported quarters were loss-making. ## How much revenue does Scotts Miracle-Gro make, and is it growing? The Scotts Miracle-Gro Company reported $1.2 B of revenue in the Jun 2026 quarter, +1.1% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 4 years it has grown −8.8% a year on average. The last full year, FY25, came in at $3.4 B. The last four reported quarters add to $3.4 B. FY25 revenue was $3.4 B, −3.9% on the year before. Recent pace: the last four quarters grew −0.9% on average, against −8.8% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +1.3%, against −2.0% a year over the last 8 quarters (accelerating). ## How much of every $100 of sales does Scotts Miracle-Gro keep? The Scotts Miracle-Gro Company's operating margin was 16.8% in the Jun 2026 quarter, 2.4 percentage points lower than the same quarter a year ago. Across 5 years it has been between 8.2% and 15.3%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed −2.4 percentage points on the year while gross margin changed −1.0 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Scotts Miracle-Gro's profit turning into cash? Over the last 2 years, 98% of The Scotts Miracle-Gro Company's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $371 M of operating cash against $145 M of profit. After $97.4 M of spending on assets, $274 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Scotts Miracle-Gro's cash go? The Scotts Miracle-Gro Company does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $274 M on assets over the last 3 years. Averaged over those years that is 2.7% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $274 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Scotts Miracle-Gro's P/E ratio, and how does it compare with its own history? The Scotts Miracle-Gro Company's P/E is 49.5×, in the middle of its own history: higher than 65% of past readings. Its usual P/E (the middle reading) is 40.4×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Scotts Miracle-Gro business getting better or worse? The Scotts Miracle-Gro Company's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The return-on-capital line is not shown: net worth is negative, so a return on capital means nothing. The balance sheet is in distress, and this reading uses the growth lines alone. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Scotts Miracle-Gro earn on its capital? The Scotts Miracle-Gro Company earned a ROE of −41% in FY25. That is up from a low of −296% in FY22. Its return on capital used (ROIC) is 4.1 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 4.3% net margin and 1.24× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 4.3% net margin × 1.24× asset turnover × −7.67× leverage (assets divided by equity) ≈ −40.9% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 13.8% − 9.7% = +4.1 percentage points. The 9.7% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. ## Does Scotts Miracle-Gro have too much debt? The Scotts Miracle-Gro Company's net worth is negative: it owes more than it owns, so a debt-to-equity ratio means nothing here. Year by year, that ratio went from 2.57 in FY21 to −6.66 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Scotts Miracle-Gro shareholding pattern? 12.8% of The Scotts Miracle-Gro Company's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 4.8 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Scotts Miracle-Gro from balance-sheet trouble? For The Scotts Miracle-Gro Company, the Z-score is 2.49. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.49 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Scotts Miracle-Gro rank in its industry? 63.5 out of 100, rank 4 of 11 in Agricultural Inputs, with 85% of the evidence available. The Scotts Miracle-Gro Company scores 63.5 out of 100 against the 11 companies it is compared with in Agricultural Inputs, ranking 4. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 18.1 + 17.4 + 11.2 + 16.8 = 63.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Scotts Miracle-Gro compared with? Scotts Miracle-Gro ranks 4 of 11 Agricultural Inputs companies on the 4-Factor Sector Score, with 63.5 out of 100. 1. [CF Industries Holdings, Inc.](https://www.sectoralpha.in/us/stocks/cf) CF · turning · Sector-leading setup · 85% evidence 86.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.4/35 · Revenue 20% · Profit 61.2% · Operating margin change 15.3 points · 95% evidence Capital efficiency 20.4/25 · ROCE 20.8% · Operating margin 49.3% · 76% evidence Valuation 15.9/20 · P/E 7.9× · PEG 0.24 · 65% evidence Relative strength 18.7/20 · Lead over its industry 38.7% · Lead over S&P 500 1.8% · 1 year 42.4% · 100% evidence · 4 of 12 weeks ahead Exact sum: 31.4 + 20.4 + 15.9 + 18.7 = 86.4 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [CVR Partners, LP](https://www.sectoralpha.in/us/stocks/uan) UAN · quiet · Sector-leading setup · 85% evidence 82.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.2/35 · Revenue 17.3% · Profit 83% · Operating margin change 14.8 points · 95% evidence Capital efficiency 18.8/25 · ROCE 20.2% · Operating margin 42.4% · 76% evidence Valuation 16.2/20 · P/E 7.4× · PEG 0.06 · 65% evidence Relative strength 15.4/20 · Lead over its industry 31% · Lead over S&P 500 -3.7% · 1 year 19% · 100% evidence · 5 of 12 weeks ahead Exact sum: 32.2 + 18.8 + 16.2 + 15.4 = 82.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Nutrien Ltd.](https://www.sectoralpha.in/us/stocks/ntr) NTR · turning · Most evidence points up · 75% evidence 65.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Revenue 9.1% · Profit 73.3% · Operating margin change -0.3 points · 95% evidence Capital efficiency 14.5/25 · ROCE 8.7% · Operating margin 17.5% · 76% evidence Valuation 10.3/20 · P/E 12.7× · PEG n/a · 15% evidence Relative strength 15.6/20 · Lead over its industry 30.3% · Lead over S&P 500 -4.4% · 1 year 21.9% · 100% evidence · 6 of 12 weeks ahead Exact sum: 25.1 + 14.5 + 10.3 + 15.6 = 65.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. The Scotts Miracle-Gro Company this page SMG · turning · Evidence leans up · 85% evidence 63.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue 1.3% · Profit 39.6% · Operating margin change -2.4 points · 95% evidence Capital efficiency 17.4/25 · ROCE 22.8% · Operating margin 16.8% · 76% evidence Valuation 11.2/20 · P/E 55× · PEG 1.15 · 65% evidence Relative strength 16.8/20 · Lead over its industry 31.1% · Lead over S&P 500 -4% · 1 year 9.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 18.1 + 17.4 + 11.2 + 16.8 = 63.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [ICL Group Ltd](https://www.sectoralpha.in/us/stocks/icl) ICL · quiet · Evidence leans up · 85% evidence 58.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 10.9% · Profit -16.9% · Operating margin change 2.6 points · 95% evidence Capital efficiency 11.9/25 · ROCE 8.1% · Operating margin 12.5% · 76% evidence Valuation 14.7/20 · P/E 21.1× · PEG 0.11 · 65% evidence Relative strength 11.4/20 · Lead over its industry 5.7% · Lead over S&P 500 -22.5% · 1 year -22.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 11.9 + 14.7 + 11.4 = 58.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Intrepid Potash, Inc.](https://www.sectoralpha.in/us/stocks/ipi) IPI · quiet · Evidence leans down · 67% evidence 46.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 7.8% · Profit n/a · Operating margin change -0.8 points · 71% evidence Capital efficiency 7.1/25 · ROCE 2.9% · Operating margin 2.5% · 76% evidence Valuation 10.0/20 · P/E 16.4× · PEG n/a · 15% evidence Relative strength 11.9/20 · Lead over its industry 15.8% · Lead over S&P 500 -15.7% · 1 year 22% · 100% evidence · 3 of 12 weeks ahead Exact sum: 17.3 + 7.1 + 10 + 11.9 = 46.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Del Monte Corporation](https://www.sectoralpha.in/us/stocks/dmc) DMC · quiet · Evidence leans down · 75% evidence 40.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.2/35 · Revenue -0.2% · Profit -77.3% · Operating margin change -1.8 points · 95% evidence Capital efficiency 9.2/25 · ROCE 5.6% · Operating margin 3.9% · 76% evidence Valuation 9.4/20 · P/E 40.9× · PEG n/a · 15% evidence Relative strength 10.8/20 · Lead over its industry 2.3% · Lead over S&P 500 -25.6% · 1 year -27.2% · 100% evidence · 1 of 12 weeks ahead Exact sum: 11.2 + 9.2 + 9.4 + 10.8 = 40.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [The Mosaic Company](https://www.sectoralpha.in/us/stocks/mos) MOS · quiet · Evidence leans down · 75% evidence 35.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.8/35 · Revenue 8.8% · Profit -168.1% · Operating margin change -8.2 points · 95% evidence Capital efficiency 6.6/25 · ROCE 2.5% · Operating margin -0.1% · 76% evidence Valuation 10.6/20 · P/E 9× · PEG n/a · 15% evidence Relative strength 8.5/20 · Lead over its industry 0.3% · Lead over S&P 500 -27% · 1 year -28% · 100% evidence · 3 of 12 weeks ahead Exact sum: 9.8 + 6.6 + 10.6 + 8.5 = 35.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Corteva, Inc.](https://www.sectoralpha.in/us/stocks/ctva) CTVA · basing · Most evidence points down · 75% evidence 33.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.8/35 · Revenue -40.3% · Profit -132.5% · Operating margin change -14.4 points · 95% evidence Capital efficiency 12.3/25 · ROCE 11.6% · Operating margin 12.8% · 76% evidence Valuation 9.1/20 · P/E 41.9× · PEG n/a · 15% evidence Relative strength 0.0/20 · Lead over its industry -77.3% · Lead over S&P 500 -83.9% · 1 year -81.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 11.8 + 12.3 + 9.1 + 0 = 33.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [FMC Corporation](https://www.sectoralpha.in/us/stocks/fmc) FMC · quiet · Most evidence points down · 75% evidence 24.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 4.3/35 · Revenue -21.3% · Profit -2802.9% · Operating margin change -3.7 points · 95% evidence Capital efficiency 6.2/25 · ROCE 1.5% · Operating margin 11.8% · 76% evidence Valuation 8.8/20 · P/E 52.7× · PEG n/a · 15% evidence Relative strength 4.7/20 · Lead over its industry -36.3% · Lead over S&P 500 -54.3% · 1 year -56.5% · 100% evidence · 1 of 12 weeks ahead Exact sum: 4.3 + 6.2 + 8.8 + 4.7 = 24 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Glass House Brands Inc.](https://www.sectoralpha.in/us/stocks/glas) GLAS · quiet · Most evidence points down · 75% evidence 17.7 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Agricultural Inputs](https://www.sectoralpha.in/us/sectors/agricultural-inputs), all 11 compared on one page. ## Which companies are close to Scotts Miracle-Gro in size? Scotts Miracle-Gro is the 6th largest of 11 Agricultural Inputs companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Corteva, Inc., The Mosaic Company and ICL Group. Just below it: Del Monte Corporation, CVR Partners, LP and FMC Corporation. ### Agricultural Inputs companies close in size

1. [Corteva, Inc.](https://www.sectoralpha.in/us/stocks/ctva) $7.9 billion
2. [The Mosaic Company](https://www.sectoralpha.in/us/stocks/mos) $5.9 billion
3. [ICL Group Ltd](https://www.sectoralpha.in/us/stocks/icl) $5.6 billion
4. The Scotts Miracle-Gro Company $3.6 billion
5. [Del Monte Corporation](https://www.sectoralpha.in/us/stocks/dmc) $1.3 billion
6. [CVR Partners, LP](https://www.sectoralpha.in/us/stocks/uan) $1.3 billion
7. [FMC Corporation](https://www.sectoralpha.in/us/stocks/fmc) $947 million

[All 11 Agricultural Inputs companies, largest first](https://www.sectoralpha.in/us/sectors/agricultural-inputs#all-companies)

### Companies close in size in other industries

1. [PLDT Inc.](https://www.sectoralpha.in/us/stocks/phi) $3.8 billion · Telecom Services
2. [Oceaneering International, Inc.](https://www.sectoralpha.in/us/stocks/oii) $3.8 billion · Oil & Gas Equipment & Services
3. The Scotts Miracle-Gro Company $3.8 billion
4. [First Advantage Corporation](https://www.sectoralpha.in/us/stocks/fa) $3.8 billion · Specialty Business Services
5. [Relay Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/rlay) $3.8 billion · Biotechnology

## What else do people ask about Scotts Miracle-Gro? ### What were Scotts Miracle-Gro's latest quarterly results? The Scotts Miracle-Gro Company reported revenue of $1.2 B and net profit of $112 M for the Jun 2026 quarter. Revenue rose 1.1% and profit fell 24.7% compared with a year earlier. Earnings per share were $1.90. The operating margin was 16.8%, 2.4 percentage points lower than a year earlier (as of 3 November 2026). ### What is Scotts Miracle-Gro's market cap? The Scotts Miracle-Gro Company's market capitalisation is $3.6 B at a stock price of $61.80. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Scotts Miracle-Gro performing? The Scotts Miracle-Gro Company's share price has been moving sideways for 1 weeks. In its latest quarter, revenue rose 1.1% and profit fell 24.7% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 1 week running (as of 3 November 2026). ### Will Scotts Miracle-Gro's stock price go up? This page does not forecast The Scotts Miracle-Gro Company's stock price. What it shows instead: the stock price is $61.80, and it has been moving sideways for 1 weeks. Its P/E of 49.5× is higher than 65% of its own last 5 years (as of 3 November 2026). ### Where is Scotts Miracle-Gro in its business cycle? The Scotts Miracle-Gro Company's FY25 operating margin was 13.0%, against a 5-year range of 8.2% to 15.3%: the middle of its own range, neither a peak nor a low. The latest quarter was 16.8%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Scotts Miracle-Gro story? Biggest thing to watch: the P/E is higher than 65% of its own history, so the multiple has already done part of the work. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Scotts Miracle-Gro a stock worth studying right now? What the numbers show: The Scotts Miracle-Gro Company's balance sheet is under water: its net worth is negative, so it owes more than it owns. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. The main open question: whether the business can earn its way back to positive net worth before new shares or a restructuring get there first. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.